Another lawsuit filed to stop implementation of new USPTO rules, this time by a heavy hitter

October 11, 2007
Post by Blog Staff

Pharmaceutical giant GlaxoSmithKline filed a lawsuit in the Eastern District of Virginia seeking to stop implementation of the new continuation and claim limit rules. The lawsuit, filed Tuesday, seeks a preliminary and permanent injunction against the rules' implementation. The complaint has eight counts:

  1. The Rules are ultra vires because the USPTO does not have the statutory authority to issues substantive rules in the area
  2. The USPTO "especially lacks the authority" to implement the continuation application limits
  3. The rules impermissibly "retroactively change the legal consequences of already filed continuation applications and patent prosecution strategies"
  4. The USPTO doesn't have authority to limit the number of claims that can be presented in an application
  5. The restrictions on continued examinations are contrary to the Patent Act
  6. The rules are defective for failing to provide the required notice and comment period before they were amended in ways that could not have been reasonably anticipated
  7. The rules are impermissibly vague
  8. The rules "work an unconstitutional, ultra vires, and arbitrary and capricious taking" of patent and patent application property rights

Click here to read the full complaint. With the power and motivation of a pharmaceutical giant like GlaxoSmithKline, the lawsuit will certainly be vigorously pursued, particularly given that pharmaceutical and biotech patents will be the most adversely affected by the new rules.

Hat tip to Gene Quinn at the PLI Patent Law Blog, who also provided the copy of the complaint.

Update (10/12): The Wall Street Journal Law Blog has picked up the story, and has a call in to the USPTO for comment. It will be interesting to see what the Office has to say.

Post Categories

Comments (0)
Post a Comment

Captcha Image
Return to the Filewrapper Blog

Search Posts


The attorneys of McKee, Voorhees & Sease, P.L.C. designed this blog as an informational and educational resource about intellectual property law for our clients, other attorneys, and the public as a whole. Our goal is to provide cutting-edge information about recent developments in intellectual property law, including relevant case law updates, proposed legislation, and intellectual property law in the news.


McKee, Voorhees & Sease, P.L.C. provides this blog for general informational purposes only. By using this blog, you agree that the information on this blog does not constitute legal or other professional advice and no attorney-client or other relationship is created between you and McKee, Voorhees & Sease, P.L.C. Do not consider this blog to be a substitute for obtaining legal advice from a qualified, licensed attorney. While we try to revise this blog on a regular basis, it may not reflect the most current legal developments. We consciously refrain from expressing opinions on this blog and instead, offer it as a form of information and education, however if there appears an expression of opinion, realize that those views are indicative of the individual and not of the firm as a whole.

Connect with MVS

Enter your name and email address to recieve the latest news and updates from us and our attorneys.

Subscribe to: MVS Newsletter

Subscribe to: Filewrapper® Blog Updates

  I have read and agree to the terms and conditions of McKee, Voorhees & Sease, P.L.C.